C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2002
12/25/2002	CN1387087A Color coupler for forming dye, silver halide photosensitive material and azomethine dyes compounds
12/25/2002	CN1097052C Process for production of amidinoindole derivs, and salts thereof
12/25/2002	CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists
12/25/2002	CN1097050C Substd 2,4-imidazolidinedione compounds and pharmaceutical active ingredients
12/24/2002	US6498257 2,3-olefinic epothilone derivatives
12/24/2002	US6498255 Cholinesterase inhibitors; cognition activators; alzheimer's disease; e.g., 3-(2-(1-(phenylmethyl)-4-piperidinyl)ethyl)-1,2-benzisoxazole
12/24/2002	US6498185 Enzyme factor xa inhibitors
12/24/2002	US6498179 Such as 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl)-2-(2-methyl-1 -imidazolyl)oxazole; insulin secertion promoting and blood sugar depressing effect; diabetes; low toxicity
12/24/2002	US6498178 Inhibitors of IMPDH enzyme
12/24/2002	US6498177 Alpha 2 adrenergic receptor agonist; analgesic, sedative and anaesthetic agents
12/24/2002	US6498174 Agonists to peroxisome proliferator-activated receptors; modulating blood glucose and lipid levels; reducing dyslipidemia and hyperinsulinemia associated with impaired glucose tolerance or metabolic syndrome
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498170 4-((2s)-3-(1-(4-butoxy-benzenesulfonyl)-azetidin-3-ylamino)-2 -hydroxy- propoxy)-phenol for example; hypoglycemic agent; increasing lean meat to fat ratio in mammals
12/24/2002	US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002	US6498161 Treating infection by hiv; delaying of the onset of aids; asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis
12/24/2002	US6498160 For therapy of emphysema, chronic bronchitis, asthma and allergic rhinitis
12/24/2002	US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile
12/24/2002	US6498158 Il-5 inhibiting 6-azauracil derivatives
12/24/2002	US6498125 Pyridine ketones useful as herbicides
12/24/2002	US6498004 Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
12/24/2002	US6497730 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibers, dyeing compositions and methods
12/19/2002	WO2002101073A2 Aryl-benzimidazole compounds having antiinfective activity
12/19/2002	WO2002101007A2 Antipathogenic benzamide compounds
12/19/2002	WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002	WO2002100852A1 Benzothiophene compounds having antiinfective activity
12/19/2002	WO2002100851A2 Thiophene derivatives as antiviral agents for flavivirus infection
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002	WO2002100832A1 Isoquinoline compounds having antiinfective activity
12/19/2002	WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	WO2002100818A2 Aminediols as agents for the treatment of alzheimer's disease
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002100433A1 Medicinal compositions
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002100368A1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002	WO2002072858A3 Degradation of epothilones and ethynyl substituted epothilones
12/19/2002	WO2002069972A3 Triazole compounds and the use thereof in the prophylaxis and therapy of neurodegenerative diseases, cerebral trauma and cerebral ischemia
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002	WO2002050082A3 Inhibitors of papilloma virus
12/19/2002	WO2001047919A9 Substituted oxazolidinones and their use in the field of blood coagulation
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002	US20020193407 Modulators of CCR5 chemokine receptor activity
12/19/2002	US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
12/19/2002	US20020193390 Pharmaceutical compositions containing an N-(substituted glycyl)-2- cyanopyrrolidine and at least one other antidiabetic agent and their use in inhibiting dipeptidyl peptidase-IV
12/19/2002	US20020193367 Dihydro-benzo [b] [1,4] diazepin-2-one derivatives
12/19/2002	US20020193361 For therapy of cancer and other conditions characterized by abnormal cellular proliferation
12/19/2002	CA2450628A1 Benzothiophene compounds having antiinfective activity
12/19/2002	CA2450625A1 Isoquinoline compounds having antiinfective activity
12/19/2002	CA2450400A1 Medicinal compositions
12/19/2002	CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450205A1 Aminediols for the treatment of alzheimer's disease
12/19/2002	CA2449629A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	CA2449544A1 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/18/2002	EP1266950A1 Lubricant composition containing a triazine molecular complex compound
12/18/2002	EP1266896A1 Linear ou cyclic ureas, process for their preparation and pharmaceutical compositions containing them
12/18/2002	EP1266887A2 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
12/18/2002	EP1265921A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor
12/18/2002	EP1265893A1 Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
12/18/2002	EP1265892A1 Isothiazole derivatives and their use as pesticides
12/18/2002	EP1265889A1 Medicaments against viral diseases
12/18/2002	EP1265878A1 A process for the preparation of epothiline analogs and intermediates
12/18/2002	EP1265872A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
12/18/2002	EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1064273B1 1,3,4-thiadiazoles useful for the treatment of cmv infections
12/18/2002	EP0882038B1 substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
12/18/2002	EP0869949B1 Benzoxazine antimicrobial agents
12/18/2002	EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
12/18/2002	CN1386120A 萘酚衍生物 Naphthol derivative
12/18/2002	CN1096460C Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for treatment of allergic diseases
12/18/2002	CN1096448C Farnesyl transferase inhibitors, its preparation and medicine composition thereof
12/18/2002	CN1096265C Preparation of pharmaceutical composition containing novel thiazolidone and oxazolidone
12/17/2002	US6495692 Helium-neon excitable reticulocyte dyes derivable from halolepidines
12/17/2002	US6495582 Erk (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
12/17/2002	US6495573 Non-systemic control of parasites
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495561 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
12/17/2002	US6495551 Substituted phenyloxazolidinones and their use as antibiotics
12/17/2002	US6495550 Substituted benzamido-pyridine derivatives for treatment of disorders mediated by potassium channels
12/17/2002	US6495547 Hampered or impaired relaxation of the fundus to food ingestion; irritable bowel syndrome, anorexia, bloating, early satiety, dyspepsia
12/17/2002	US6495546 Propanolamine derivatives
12/17/2002	US6495545 1,4-benzodiazepinone derivatives and their use as integrin antagonists
12/17/2002	US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome
12/12/2002	WO2002099428A1 Luciferin hydrazides
12/12/2002	WO2002099388A2 Benzodiazepine bradykinin antagonists
12/12/2002	WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002	WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases

1 ... 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 ... 628